Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Suman Laal
New York University School of Medicine, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Stellar Diagnostics India Pvt Ltd
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Laal made an invention disclosure for a point-of-care test that would measure in HIV-patients their susceptibility of developing full-blown tuberculosis. Stellar Diagnostics India was formed by Dr. Laal and co-founders in India for the purpose of licensing and developing this NYU-owned invention. Dr. Laal owns shares of Stellar Diagnostics India. The goal of this HIV Research Training Program is to provide training and capacity building for fostering basic research on understanding the pathogenesis of pulmonary and extrapulmonary TB, especially in HIV+ patients, with the ultimate goal of devising rapid, simple and accurate point-of-care methods for diagnosis of active and subclinical, pulmonary and extrapulmonary TB.
Research Training on Pathogenesis and Diagnosis of HIV-TB
This HIV Research Training Program will help to build sustainable research capacity in Post Graduate Institute of Medical Education and Research in India by enhancing the scientific expertise of investigators in performing research that will address the challenges created by dual epidemics of HIV and TB. The goal is to provide training and capacity building for fostering basic research on understanding the pathogenesis of pulmonary and extrapulmonary TB, especially in HIV+ patients, with the ultimate goal of devising rapid, simple and accurate point-of-care methods for diagnosis of active and subclinical, pulmonary and extrapulmonary TB Immigrants from TB-endemic countries continue to be the major population subset that is diagnosed with TB in the US. The project is also highly relevant to the public health of the United States and its citizens.
Filed on February 23, 2017.
Tell us what you know about Suman Laal's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.